Novorapid and Hypokalaemic syndrome - from FDA reports
Hypokalaemic syndrome is found among people who take Novorapid, especially for people who are female, 60+ old , have been taking the drug for < 1 month, also take medication Lantus, and have Type 2 diabetes. This study is created by eHealthMe based on reports of 12,907 people who have side effects when taking Novorapid from FDA, and is updated regularly.
How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.
Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).
12,907 people reported to have side effects when taking Novorapid.
Among them, 110 people (0.85%) have Hypokalaemic syndrome
Number of reports submitted per year:
Time on Novorapid when people have Hypokalaemic syndrome *:
- < 1 month: 80.77 %
- 1 - 6 months: 3.85 %
- 6 - 12 months: 15.38 %
Gender of people who have Hypokalaemic syndrome when taking Novorapid *:
- female: 56.88 %
- male: 43.12 %
Age of people who have Hypokalaemic syndrome when taking Novorapid *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 10.48 %
Top conditions involved for these people *:
- High Blood Pressure: 17 people, 15.45%
- Type 2 Diabetes: 17 people, 15.45%
- Preventive Health Care: 8 people, 7.27%
- Pain: 8 people, 7.27%
- Oedema (fluid collection in tissue): 7 people, 6.36%
Top co-used drugs for these people *:
- Lantus: 34 people, 30.91%
- Levemir: 19 people, 17.27%
- Slow-K: 15 people, 13.64%
- Aldactone: 14 people, 12.73%
- Lasix: 13 people, 11.82%
Top other side effects for these people *:
- Hypoglycemia (low blood sugar): 24 people, 21.82%
- Diarrhea: 10 people, 9.09%
- Anaemia (lack of blood): 10 people, 9.09%
- Malaise (a feeling of general discomfort or uneasiness): 10 people, 9.09%
- Breathing Difficulty: 8 people, 7.27%
* Approximation only. Some reports may have incomplete information.
FDA reports used in this study
- Want to find out more about the FDA reports used in the study? You can request them from FDA.
Do you have Hypokalaemic syndrome while taking Novorapid?
- Check whether a drug or a condition causes Hypokalaemic syndrome
- Subscribe to monitor Hypokalaemic syndrome in Novorapid
You are not alone:
Novorapid has active ingredients of insulin aspart recombinant. It is often used in type 1 diabetes. (latest outcomes from Novorapid 13,003 users)
Hypokalaemic syndrome (serum concentration of potassium <3.5) has been reported by people with high blood pressure, osteoporosis, pain, depression, multiple myeloma (latest reports from 41,422 Hypokalaemic syndrome patients).
Drugs that are associated with Hypokalaemic syndromeHypokalaemic syndrome (2,490 drugs)
Could your condition cause Hypokalaemic syndromeHypokalaemic syndrome (2,335 conditions)
Novorapid side effects
- Novorapid side effects (12,933 reports)
Browse all side effects of Novorapida b c d e f g h i j k l m n o p q r s t u v w x y z
What would happen?
Recent general studies
- Will you have Tingling In Hands Or Feet with Glucosamine Sulfate? - now
- Will you have Carcinoma - Lobular with Fluvastatin Sodium? - a second ago
- Will you have Carcinoma - Ductal with Fluvastatin Sodium? - a second ago
- Will you have Cancer - Breast with Fluvastatin Sodium? - a second ago
- Will you have Breast Cancer with Fluvastatin Sodium? - a second ago
Recent personal studies
- Drug comparison of Sulfasalazine, Actemra for a 47 year old woman - 38 minutes ago
- A study for a 47 year old woman who takes Sulfasalazine, Actemra - 44 minutes ago
- A study for a 55 year old woman who takes Cosentyx - an hour ago
- A study for a 19 year old girl who takes Humira - 3 hours ago
- A study for a 29 year old man who takes Sertraline, Prilosec - 3 hours ago
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.